Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00266578
Status:
COMPLETED
Last Update Posted:
2013-04-11
First Post:
2005-12-15
Brief Title:
A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
Sponsor:
Marc Rothenberg
Organization:
Childrens Hospital Medical Center Cincinnati
Study Overview
Official Title:
Effect of Swallowed Fluticasone Propionate on Eosinophilic Esophagitis A Prospective Randomized Placebo-Controlled Trial
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is assessing the efficacy of swallowed Flovent vs placebo for the treatment of eosinophilic esophagitis EE
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| FAAN | None | None | None |